Yahoo Web Search

Search results

  1. Julie Louise Gerberding (born August 22, 1955) is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH).

  2. Mar 1, 2022 · March 1, 2022 10:15 am ET. KENILWORTH, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Julie L. Gerberding, chief patient officer and executive vice president, population health and sustainability, will be retiring from Merck in May 2022.

  3. Mar 1, 2022 · North Bethesda, MD, March 1, 2022 – The Foundation for the National Institutes of Health (FNIH) today announced the appointment of Dr. Julie Louise Gerberding, the 15th Director of the Centers for Disease Control and Prevention (CDC) and an executive at Merck & Co., Inc., as its next Chief Executive Officer. Dr.

  4. People also ask

  5. Julie Gerberding - Foundation for the National Institutes of Health | LinkedIn. United States. 4K followers 500+ connections. Foundation for the National Institutes of Health. University of...

    • 500+
    • Bethesda, Maryland, United States
    • 3.6K
  6. Mar 18, 2022 · Dr. Julie Louise Gerberding. The Foundation for the National Institutes of Health appointed Dr. Julie Louise Gerberding as its next chief executive officer. She will assume her role on May 16.

  7. Mar 1, 2022 · Dr. Julie Gerberding Named Chief Executive Officer of the Foundation for the National Institutes of Health. International health leader committed to championing research, patient engagement,...

  8. Dec 10, 2014 · today announced the appointment of Dr. Julie Gerberding, 59, as executive vice president for strategic communications, global public policy and population health, effective Dec. 15. In this newly created Executive Committee position, Gerberding, who most recently served as president of Merck Vaccines, will be responsible for Merck’s global

  1. People also search for